
News|Slideshows|February 21, 2019
Diabetes Drugs and Cardioprotection: 8 Questions on Key Trials
Author(s)Grace Halsey
Find out what you know about which diabetes drugs in which classes show CV protective properties and results of the trials that support their use.
Advertisement
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
Sebela Submits NDA for Tegoprazan for GERD, Seeking Approval for NERD and Erosive Esophagitis
2
Avoiding Common Ordering Errors in UACR Testing, With Holly Kramer, MD
3
Weekly Dose Podcast: Needle-Free Epinephrine, Pediatric Atopic Dermatitis Gains, Smarter Dementia Screening, Teen Depression Treatment, and Oral PCSK9 Data
4
Population-Based eGFR Percentiles Linked to Kidney Failure and Mortality Risk, Study Finds
5




















































































































































































































































































































